Linezolid Denk (Linezolid)

Linezolid is indicated for bacterial infections that require coverage of resistant Gram‑positive organisms.

• Complicated skin and soft‑tissue infections: provides effective bacterial clearance and clinical cure.
• Community‑acquired and nosocomial pneumonia: improves respiratory outcomes and reduces mortality.
• Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers an alternative to vancomycin with comparable efficacy.
• Vancomycin‑resistant Enterococcus (VRE) infections: achieves bacterial eradication where other agents fail.

• Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks translation of essential proteins, leading to bacteriostatic activity against susceptible Gram‑positive organisms, including resistant strains such as MRSA and VRE.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: transient gastrointestinal upset.
• Diarrhea: loose stools, usually mild.
• Headache: mild to moderate intensity.
• Metallic taste: altered taste perception.
• Vomiting: occasional episodes.
• Rash: mild skin irritation.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count.
• Anemia: reduced red blood cell levels.
• Peripheral neuropathy: tingling or numbness in extremities.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: metabolic disturbance requiring urgent care.
• Optic neuropathy: vision changes that may be irreversible.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

• Monitor blood counts: watch for thrombocytopenia and anemia.
• Assess renal function: adjust therapy in severe impairment.
• Evaluate for drug interactions: avoid concurrent serotonergic agents.
• Use with caution in patients with a history of myelosuppression.
• Avoid use in individuals with known hypersensitivity to linezolid.
• Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs) and serotonin‑norepinephrine reuptake inhibitors (SNRIs): risk of serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): potentiate serotonergic effects.
• Tricyclic antidepressants: increase serotonin toxicity potential.

Moderate Interactions (Monitor Closely)

• Rifampin: may reduce linezolid plasma concentrations.
• Antacids containing magnesium or aluminum: can impair absorption.
• Warfarin: possible alteration of anticoagulant effect, requiring INR monitoring.